Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Hak Jong Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0858-7873; OpenAlex author ID A5087678581. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Ultrasound-Sensitive Liposomal Exatecan for Tumor-Specific Drug Release for Treatment of Pancreatic Cancer. Last author DOI 10.3390/pharmaceutics18010003↗
  2. Synergistic Effects of Pulsed Focused Ultrasound and a Doxorubicin-Loaded Microparticle-Microbubble Complex in a Pancreatic Cancer Xenograft Mouse Model. Co-author DOI 10.1016/j.ultrasmedbio.2020.07.019↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dongyeon Kim · 1 shared paper, 2025 · strength 0.37
  2. Joon Koo Han · 1 shared paper, 2020 · strength 0.12
  3. Jae Young Lee · 1 shared paper, 2020 · strength 0.12
  4. Hyo‐Jin Kang · 1 shared paper, 2020 · strength 0.12
  5. Eun-Joo Park · 1 shared paper, 2020 · strength 0.12
  6. Yun Deok Ahn · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.